Literature DB >> 11941554

Assessing eosinophil count as a marker of immune activation among human immunodeficiency virus-infected persons in sub-Saharan Africa.

T L Chorba1, J Nkengasong, T H Roels, B Monga, C Maurice, M Maran, G Djomand.   

Abstract

In 611 human immunodeficiency virus-infected persons who had not yet begun to receive antiretroviral therapy, we evaluated the linear association between absolute eosinophil count (as a surrogate for immune response to helminthic infection) and CD4+ T cell count, and between absolute eosinophil count and log virus load. Overall, no significant correlations were observed between eosinophil count and CD4+ T cell count, or between eosinophil count and log virus load.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11941554     DOI: 10.1086/339940

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Association Between Immunoglobulin E Levels and Kaposi Sarcoma in African Adults With Human Immunodeficiency Virus Infection.

Authors:  Helen Byakwaga; Arturo Barbachano-Guerrero; Dongliang Wang; Shane McAllister; Kamal Naphri; Miriam Laker-Oketta; Conrad Muzoora; Peter W Hunt; Jeffrey Martin; Christine A King
Journal:  J Infect Dis       Date:  2021-01-04       Impact factor: 5.226

2.  Differential clinical outcome of dengue infection among patients with and without HIV infection: a matched case-control study.

Authors:  Junxiong Pang; Tun-Linn Thein; David C Lye; Yee-Sin Leo
Journal:  Am J Trop Med Hyg       Date:  2015-03-30       Impact factor: 2.345

3.  Covariate random effects on the CD4 count variation during HIV disease progression in women.

Authors:  Partson Tinarwo; Temesgen Zewotir; Delia North
Journal:  HIV AIDS (Auckl)       Date:  2019-05-20

Review 4.  Respiratory viruses and eosinophils: exploring the connections.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.